PMD: Psychemedics Corp Market Cap to Earnings

Psychemedics Corp - graphic logo of issuer PMD

The market trend for Psychemedics (PMD), where the P/E ratio is -5.20, reflects the dynamics of a company that performs hair tests independently, utilizing external partners solely for sample delivery. Its status as the leading player in this niche provides Psychemedics (PMD) with significant pricing power over services for vessels and businesses. Stable positioning is supported by the accuracy of its forensics, although available rapid-testing methods are constraining profit growth.

Psychemedics Corporation (PMD) P/E Multiple: for the period 07/04/2022 - 12/21/2024
Manufactured product of Psychemedics Corp.

Defensive assets are selected based on the criterion of fundamental resilience to market volatility. Psychemedics confirms this status by retaining elite toxicologists due to the prestige of working with corporate leaders. The ratio of market value to net profit, displayed via the company's normalized P/E, measures the cost of one dollar of earnings. This metric allows for an assessment of whether the business is overbought or undervalued. Analyzing the price action helps distinguish speculative noise from the issuer's intrinsic value.

Competing companies

Price to Earnings Ratio A|Price to Earnings Ratio DGX (Quest Diagnostics Incorporated)|ILMN - Market Cap to Earnings|Price to Earnings Ratio Cologuard EXAS|Business Payback Period Revvity Corp (RVTY)|Bio-Rad Laboratories - P/E Multiple|Business Payback Period anbio.com NNNN|Sotera Health (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Corp|caredx.com - Market Cap to Net Income|Price to Earnings Ratio Maravai LifeSciences (MRVI)|Business Payback Period fulgentgenetics.com|Standard BioTools - Price to Earnings Ratio|Cytek Biosciences Inc (CTKB) - Market Cap to Earnings|OraSure Technologies Inc - P/E Multiple|Exagen Inc. (XGN) - Price to Earnings Ratio|MDXH: P/E Multiple|luciddx.com - Company Value to Net Income|PRE (Prenetics Global Limited) - P/E Multiple|Market Cap to Earnings Insight Molecular IMDX|Price to Earnings Ratio Trinity Biotech plc (TRIB)|Price to Earnings Ratio ProPhase Labs Corp PRPH|P/E Multiple AIMD (Ainos, Inc.)|codiagnostics.com (CODX) - Market Cap to Earnings|HeartSciences - P/E Multiple|BMRA (Biomerica Inc.) - Price to Earnings Multiple|CDIO: P/E Multiple|ONCO - Business Payback Period|VRAX (Virax Biolabs Group) - P/E Multiple|Price to Earnings Ratio bluejaydx.com (BJDX)|Price to Earnings Ratio Aspira Women's Health Inc. (AWH)|Business Payback Period Accelerate Diagnostics Inc.|Price to Earnings Ratio CENTOGENE N.V. CNTG|ENZ (Enzo Biochem Inc.) - Market Cap to Net Income|FRES - Price to Earnings Ratio|Genetic Technologies (GENE) - Price to Earnings Ratio|ME: P/E Multiple